{"schema_version":"secwatch.filing_event.v1","accession":"0001654954-24-000521","form_type":"8-K","ticker":"AIMD","cik":"0001014763","company_name":"Ainos, Inc.","filed_at":"2024-01-12T23:59:59+00:00","discovered_at":"2026-05-14T18:03:23.104059+00:00","generated_at":"2026-06-06T23:45:32.432670+00:00","sec_items":["1.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"confidence":"high","headline":"Ainos enters addendum to product development agreement with affiliate TCNT; defines co-development products and fees","bullets":["Addendum specifies co-development products: VOC diagnostics, AI Nose, POCT, VELDONA drug processing, lateral flow diagnostics.","Ainos to pay TCNT total fee of NT$5M (~USD$161k) over five years starting 2024.","Non-exclusive patent license for VOC and POCT: US$95k/month (plus 5% tax) for initial six months from Jan 2024.","TCNT provides facilities, equipment, mass production tech and ISO9001/13485 management; parts, raw materials, utilities excluded.","Original agreement effective Aug 2021 to Jul 2026; addendum ratified by audit committee on Jan 8, 2024."],"urls":{"canonical":"https://secwatch.observer/filing/0001654954-24-000521","json":"https://secwatch.observer/filing/0001654954-24-000521.json","markdown":"https://secwatch.observer/filing/0001654954-24-000521.md","text":"https://secwatch.observer/filing/0001654954-24-000521.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1014763/000165495424000521/0001654954-24-000521-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1014763/000165495424000521/aimd_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-06T23:45:32.432670+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"d3523ed0c2c37589b1f8d50453326bbbc52a01be","claim":"Ainos, Inc. amended Addendum Agreement with Taiwan Carbon Nano Technology Corporation valued at NT$5 million (approximately USD$161,000) (effective 2024-01-09).","evidence_excerpt":"On January 9, 2024, the Company and TCNT entered into an addendum to the Product Development Agreement (“Addendum Agreement”) in connection with the scope of co-development and certain terms.","evidence_source":"SEC 8-K Item 1.01/1.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1014763/000165495424000521/0001654954-24-000521-index.htm","confidence":0.9,"family_label":"Material Agreements","details":[{"label":"Action","value":"amendment"},{"label":"Agreement","value":"collaboration"},{"label":"Counterparty","value":"Taiwan Carbon Nano Technology Corporation"},{"label":"Value","value":"NT$5 million (approximately USD$161,000)"},{"label":"Effective","value":"2024-01-09"}],"fact_type":"material_agreement"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}